9 Meters Biopharma Inc NMTR shares are trading lower by 13.1% to $0.18 Monday morning after the company announced a 1-for-20 reverse stock split.
What Else?
9 Meters Biopharma says the reverse stock split was previously approved by 9 Meters stockholders at the annual meeting of stockholders held on June 22, 2022, with the final ratio determined by the Company's Board of Directors.
9 Meters Biopharma says the reverse stock split is intended to bring the company into compliance with Nasdaq's minimum bid price requirement. Common stock will begin trading on a split-adjusted basis commencing upon market open on October 18.
According to data from Benzinga Pro, 9 Meters Biopharma has a 52-week high of $1.35 and a 52-week low of $0.16.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.